Shenzhen BinDeBio 
Welcome,         Profile    Billing    Logout  
  Products    Diseases    Products    Trials    News 

Download options
                                                                                                      
 Phase 
N/A
1
2
3
4
 Trials
 012345678910
            
            
             
BinD19 / Shenzhen BinDeBio           
          
            
             
multi-target gene-modified CAR-T/TCR-T cell immunotherapy / Shenzhen BinDeBio           
          
            
             
CAR-T cell immunotherapy / Shenzhen BinDeBio           
          
            
             
CAR-T19/CAR-T22 immunotherapy / Shenzhen BinDeBio